Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that detects and measures the level of per- and polyfluorinated alkyl substances (PFAS), a potentially harmful ...

Years of exposure to nonstick cookware, fast-food packaging, fire-fighting gear and water-resistant household products have resulted in increased levels of PFAS, also known as "forever chemicals," in ...

Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson Cancer Center ...

In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...

Credit: Getty Images. The AD-Detect™ Test for Alzheimer's Disease is a screening test that uses plasma from a single blood draw to evaluate the levels of amyloid beta proteins. A blood-based biomarker ...

(RTTNews) - Quest Diagnostics Incorporated (DGX), a provider of diagnostic information services, Tuesday said it partnered with The University of Texas MD Anderson Cancer Center to develop a ...

Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer’s disease is now available for consumer purchase. The test helps assess the risk of ...

Advances in drug treatments for Alzheimer’s disease have opened doors for diagnostics, and Quest is the latest to walk through. The clinical testing giant has put forward a blood test designed to help ...

(RTTNews) - Quest Diagnostics (DGX), Wednesday announced the launch of a new blood test designed to confirm amyloid brain pathology due to Alzheimer's disease (AD) in patients with mild cognitive ...